Literature DB >> 208340

Partial gonadotrophin-resistance in pseudohypoparathyroidism.

J I Wolfsdorf, R L Rosenfield, V S Fang, R Kobayashi, A K Razdan, M H Kim.   

Abstract

A patient with classical Albright's pseudohypoparathyroidism was investigated because of oligomenorrhoea. Hypo-oestrogenism was associated with elevated basal gonadotrophin values [mean basal serum LH and FSH were 272 +/- 84 (SD) ng/ml and 593 +/- 83 ng/ml, resplectively (normal less than or equal to 220 and less than or equal to 400, respectively)]. The response to gonadotrophin releasing hormone (Gn-RH) was exaggerated, with maximal LH and FSH increments of 1688 and 458 ng/ml, respectively. These results and the findings on ovarian biopsy were compatible with partial ovarian resistance to gonadotrophins. This resistance could be overcome by administration of human menopausal gonadotrophins. This is the first evidence for gonadotrophin resistance in pseudohypoparathyroidism. The plasma cyclic adenosine-3',5'-monophosphate response to glucagon administration by two different protocols was about 70% that of normal control subjects. Other endocrine glands whose responses to hormones are mediated via the adenylate cyclase system evidenced minor abnormalities of questionable significance. This indirect evidence is compatible with a more extensive defect in the adenylate cyclase system in pseudohypoparathyroidism than has hitherto been suspected.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208340     DOI: 10.1530/acta.0.0880321

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  14 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Imprinting in Albright's hereditary osteodystrophy.

Authors:  S J Davies; H E Hughes
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

Review 3.  Albright's hereditary osteodystrophy.

Authors:  L C Wilson; R C Trembath
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

4.  Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.

Authors:  Z Farfel; V M Brothers; A S Brickman; F Conte; R Neer; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

5.  [Pseudohypoparathyroidism and adrenal cortex insufficiency. A case of multiple endocrinopathy due to peripheral hormone resistance].

Authors:  P Ridderskamp; R Schlaghecke
Journal:  Klin Wochenschr       Date:  1990-09-14

6.  Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.

Authors:  J A Heinsimer; A O Davies; R W Downs; M A Levine; A M Spiegel; M K Drezner; A De Lean; K A Wreggett; M G Caron; R J Lefkowitz
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  Deficient adenylate cyclase regulatory protein in renal membranes from a patient with pseudohypoparathyroidism.

Authors:  R W Downs; M A Levine; M K Drezner; W M Burch; A M Spiegel
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

8.  Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type 1a.

Authors:  M Shima; O Nose; K Shimizu; Y Seino; H Yabuuchi; T Saito
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

9.  Pseudopseudohypoparathyroidism associated with idiopathic growth hormone deficiency. Role of treatment with biosynthetic growth hormone.

Authors:  R Manfredi; A Zucchini; L Azzaroli; G Manfredi
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

10.  Parental origin of transcription from the human GNAS1 gene.

Authors:  R Campbell; C M Gosden; D T Bonthron
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.